Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Tokyo?

Source: https://theobservatory.io/articles/aesthetic-clinics-tokyo-ai-overview-control-september-14-20-2026
Scope: Luxury Medical Aesthetic Clinics Tokyo · Tokyo · AI Overview · Google · Desktop
Family: Ranking Top 10
Observed: September 14–20, 2026 (2026-09-14/2026-09-20)
Published: September 22, 2026
Method — How readings are scoped: https://theobservatory.io/method#standards
Method — Run metadata: https://theobservatory.io/method/panel#run-metadata
Method — Source protocol: https://theobservatory.io/method#source-protocol
Method — Corrections and right of reply: https://theobservatory.io/method#corrections
Public table: https://theobservatory.io/articles/aesthetic-clinics-tokyo-ai-overview-control-september-14-20-2026/data.csv
Citation text: https://theobservatory.io/articles/aesthetic-clinics-tokyo-ai-overview-control-september-14-20-2026/citation.txt
Reuse terms: https://theobservatory.io/terms

kojihifu.com holds the strongest AI opening share on the Luxury Medical Aesthetic Clinics Tokyo market across the 6-run window September 14–20, 2026, at 33.66%.

Key facts:
• kojihifu.com: 34% AI opening share · opening in 6/6 runs
• biancaclinic-tokyo.com: 22% AI opening share · opening in 6/6 runs
• clinicjapan.net: 7% AI opening share · opening in 6/6 runs

Published table — AIO opening control — top 10 (September 14–20, 2026 · 80 queries per run · 6 comparable runs): Rank · Actor · AIO opening control
1. kojihifu.com — 33.66% AI opening share · opening in 6/6 runs — #1
2. biancaclinic-tokyo.com — 22.44% AI opening share · opening in 6/6 runs — #2
3. clinicjapan.net — 6.93% AI opening share · opening in 6/6 runs — #3
4. Azabu Skin Clinic — 6.27% AI opening share · opening in 6/6 runs — #4
5. rejuva.jp — 5.94% AI opening share · opening in 6/6 runs — #5
6. instagram.com — 3.63% AI opening share · opening in 5/6 runs — #6
7. plazaclinic.net — 2.97% AI opening share · opening in 6/6 runs — #7
8. Bianca Clinic — 2.97% AI opening share · opening in 4/6 runs — #8
9. Kai Clinic Tokyo — 2.64% AI opening share · opening in 4/6 runs — #9
10. youtube.com — 2.31% AI opening share · opening in 3/6 runs — #10

Reading basis: This card observes the AI Overview opening-control rail for Luxury Medical Aesthetic Clinics Tokyo in Japan on Google desktop across 6 comparable scheduled runs in the observation period September 14–20, 2026. The top-10 panel is aggregated from 80 observed queries. Per-actor AI opening share is the sum of the actor's values across all comparable runs in the period, ranked by cumulative opening volume on one single period-wide denominator. The primary metric is AI opening share on this market. AI Overview opening-control evidence was available on 6 of 6 runs in the window.

Limitations and non-claims:
— Observes the observed AI answer surface only; within a defined scope and window.
— A period aggregate (6 comparable runs) — not a claim about bookings, revenue, or market share.
— Scoped to Luxury Medical Aesthetic Clinics Tokyo Tokyo, September 2026; not generalisable beyond this market and window.

— The Observatory · Luxury Medical Aesthetic Clinics Tokyo · Tokyo · AI Overview · Google · Desktop · September 14–20, 2026
Based on governed AAI Kernel evidence. Capture identifier: pr_1789861808558_uuy3y7. Cite freely with attribution. Published by The Observatory.
Source footnote: Sourced from a published AAI MIB card. The Observatory publishes this card’s public findings; values are as observed on the search surface, not business-market claims.
Attribution: Published by The Observatory · Based on an AAI Kernel capture · governed by The Observatory editorial system
Cite: According to The Observatory (September 22, 2026), Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Tokyo?. https://theobservatory.io/articles/aesthetic-clinics-tokyo-ai-overview-control-september-14-20-2026

This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset.
Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking.
Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date.
Revision: fc6764f84117ac9c